Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 13, 2018 07:30 ET | Source: BioElectronics Corporation

BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program

FREDERICK, MD, Aug. 13, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug...
May 29, 2018 11:48 ET | Source: BioElectronics Corporation

BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application

FREDERICK, MD, May 29, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com reports that it has cancelled today’s scheduled US Food and Drug Administration meeting....
January 04, 2018 07:00 ET | Source: BioElectronics Corporation

BioElectronics ActiPatch Drug Free Pain Therapy Receives United Kingdom National Health System Payment Coverage

FREDERICK, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com makes wearable, drug-free chronic pain therapy medical devices. It is pleased to...
December 12, 2017 08:30 ET | Source: BioElectronics Corporation

BioElectronics Announces ActiPatch: Over-The-Counter Alternative to Opioids

FREDERICK, MD, Dec. 12, 2017 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced wearable consumer pain management medical device, ActiPatch, announced today the...
December 07, 2017 08:30 ET | Source: BioElectronics Corporation

BioElectronics Announces the Launch of the ‘Try & Tell’ Program

FREDERICK, MD, Dec. 07, 2017 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced wearable consumer pain management medical device ActiPatch, announced today the...